ARTICOMPLEX

 120 CÁPSULAS DE 650 MG

Descrição: As cápsulas do ARTICOMPLEX são uma simbiose de plantas tradicionalmente usadas pela população sul americana para todo o tipo de sintomas de artrites,dores articulares e musculares, deformações e lesões.

 

Usos Tradicionais: Para dores articulares, musculares, contusões, deformações e lesões. Em artrites, reumatismos e todo o tipo de queixas osteo-articulares.

Ingredientes: Uncaria tomentosa, Maytenus krukuvii, Desmodium adscendens, Cayaponia tayuya, Bidens pilosa, Alchornea castaneifolia, Smilax officinalis, Mikania guaco.

Sugestão de uso: 3 cápsulas 2-3 vezes ao dia. Em caso de necessidade pode-se tomar 2 a 3 cápsulas em intervalos de 2 a 4 horas.

Contra-Indicações:  Não deve ser usado durante a gravidez ou durante a amamentação.

Interacções  medicamentosas: Nenhuma relatada.

 

Propriedades.

  • A Cayaponia tayuya tem propriedades analgésicas, anti-inflamatórias, antioxidantes.

  • A Uncaria tomentosa é imuno estimulante, antinflamatória, antimutagénica e antiulcerosa.

  • A Maytenus krukuvii é analgésica, relaxante múscular, e antinflamatória para a artrite, reumatismo e dores lombares.

  • A Desmodium adscendens é antispasmódica, relaxante  muscular, anti-artrítica, reduz as dores musculares e articulares.

  • A Cayaponia tayuya  alivia todos os tipos de dores (artrite, enxaquecas e dores de cabeça, dores de estômago, dor menstrual, etc.)

  • A Bidens pilosa antiespasmódica, anti-inflamatória, usa-se em artrites, reumatismos, e outras condições inflamatórias.

  • A Alchornea castaneifolia alivia a dor, reduz a inflamação, é usada na artrite e no reumatismo.

  • A Smilax officinalis é anti-inflamatória, anti-reumática, alivia a dor.  

  • A Mikania guaco é analgésica, anti-inflamatória nas artrites.

 

PESQUISAS E ESTUDOS PUBLICADOS SOBRE ESTAS DIVERSAS PLANTAS

Cayaponia tayuya

Anti-inflammatory, Pain-Relieving & Anti-arthritic Actions:
Escandell, J. M., et al. "Inhibition of delayed-type hypersensitivity by Cucurbitacin R through the curbing of lymphocyte proliferation and cytokine expression by means of nuclear factor AT translocation to the nucleus." J Pharmacol Exp Ther. 2010 Feb;332(2):352-63.
Aquila, S., et al. "Anti-inflammatory activity of flavonoids from Cayaponia tayuya roots." J Ethnopharmacol. 2009 Jan 21;121(2):333-7.
Escandell, J., et al. "Dihydrocucurbitacin B inhibits delayed type hypersensitivity reactions by suppressing lymphocyte proliferation." J Pharmacol Exp Ther. 2007 Sep;322(3):1261-8.
Siqueira, J., et al. "Anti-inflammatory effects of a triterpenoid isolated from Wilbrandia ebracteata Cogn." Life Sci. 2007 Mar 20;80(15):1382-7.
Escandell, J. M., et al. "Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in Lewis rats by suppression of TNF-{alpha} in T lymphocytes and macrophages." J. Pharmacol. Exp. Ther. 2006 Feb; 532(1-2): 145-54.
Escandell, J. M., et al. “Dihydrocucurbitacin B, isolated from Cayaponia tayuya, reduces damage in adjuvant-induced arthritis.” Eur. J. Pharmacol. 2006 Feb; 532(1-2): 145-54.
Recio, M. C., et al. “Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia tayuya roots.” Planta Med. 2004; 70(5): 414-20.
Himeno, E., et al. “Structures of cayaponosides A, B, C and D, glucosides of new nor-cucurbitacins in the roots of Cayaponia tayuya.” Chem. Pharm. Bull. (Tokyo) 1992; 40(10): 2885–87.
Ruppelt, B. M., et al. “Pharmacological screening of plants recommended by folk medicine as anti-snake venom—I. Analgesic and anti-inflammatory activities.” Mem. Inst. Oswaldo Cruz 1991; 86 (Suppl. 2): 203–5.
Rios, J. L., et al. “A study of the anti-inflammatory activity of Cayaponia tayuya root.” Fitoterapia 1990; 61(3): 275–78.
Faria, M. R. and E. P. Schenkel. “Caracterizacao de cucurbitacinas em especies vegetais cohecidas popularmente como taiuiá.” Ciencia e Cultura (São Paulo) 1987; 39: 970–73.
Bauer, R., et al. “Cucurbitacins and flavone C-glycosides from Cayaponia tayuya.” Phytochemisty. 1984: 1587–91.

Uncaria tomentosa

Anti-inflammatory Actions:
Akhtar, N., et al. "Current nutraceuticals in the management of osteoarthritis: a review." Ther Adv Musculoskelet Dis. 2012 Jun;4(3):181-207.
Rojas-Duran, R., et al. "Anti-inflammatory activity of Mitraphylline isolated from Uncaria tomentosa bark." J Ethnopharmacol. 2012 Oct 11;143(3):801-4.
Allen-Hall, L., et al. "Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB." J. Ethnopharmacol. 2010 Feb 17;127(3):685-93.
Zeng, K., et al. "Synthesis and biological evaluation of quinic acid derivatives as anti-inflammatory agents." Bioorg. Med. Chem. Lett. 2009 Sep 15; 19(18): 5458-60.
Erowele, G., et al. "Pharmacology and therapeutic uses of cat's claw." Am. J. Health Syst. Pharm. 2009 Jun 1; 66(11): 992-5.
Amaral, S., et al. "Plant extracts with anti-inflammatory properties--a new approach for characterization of their bioactive compounds and establishment of structure-antioxidant activity relationships." Bioorg. Med. Chem. 2009 Mar; 17(5): 1876-83.
Yuan, D., et al. "Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism." Int. Immunopharmacol. 2009 Dec; 9(13-14):1549-54.
Pero, R. "Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals." United States Patent No. 7,595,064. September 29, 2009
Hardin, S. R. "Cat's claw: An Amazonian vine decreases inflammation in osteoarthritis." Complement. Ther. Clin. Pract. 2007 Feb; 13(1): 25-8.
Allen-Hall, L., et al. "Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1beta and TNF-alpha." J. Ethnopharmacol. 2007 Jan; 109(2): 312-7.
Badilla, B., et al. "Edema induced by Bothrops asper (Squamata: Viperidae) snake venom and its inhibition by Costa Rican plant extracts." Rev. Biol. Trop. 2006 Jun; 54(2):245-52.
Miller, M. J., et al. "The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta." BMC Complement. Altern. Med. 2006 Apr; 6: 13.
Miller, M. J., et al. "Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: a randomized controlled trial [ISRCTN38432711]." J. Inflamm. 2005 Oct; 2:11.
Valerio, L. G., et al. "Toxicological aspects of the South American herbs cat's claw (Uncaria tomentosa) and Maca (Lepidium meyenii): a critical synopsis." Toxicol. Rev. 2005; 24(1): 11-35.
Setty, A. R., et al. "Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects." Semin. Arthritis Rheum. 2005; 34(6): 773-84.
Sheng, Y., et al. “An active ingredient of Cat's Claw water extracts: identification and efficacy of quinic acid.” J. Ethnopharmacol. 2005 Jan 15; 96(3):
Aguilar, J. L., et al. “Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae).” J. Ethnopharmacol. 2002; 81(2): 271–76.
Sandoval, M., et al., “Anti-inflammatory and antioxidant activities of cat’s claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content." Phytomedicine. 2002; 9(4): 325–37.
Mur, E., et al. “Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis.” J. Rheumatol. 2002 Apr; 29(4): 678–81.
Sandoval-Chacon, M., et al. “Anti-inflammatory actions of cat’s claw: the role of NF-kappaB.” Aliment. Pharmacol. Ther. 1998; 12(12): 1279–89.
Recio, M. C., et al. “Structural requirements for the anti-inflammatory activity of natural triterpenoids.” Planta Med. 1995; 61(2): 182–85.
Aquino, R., et al. “Plant metabolites. New compounds and anti-inflammatory activity of Uncaria tomentosa." J. Nat. Prod. 1991; 54: 453–59.
Cerri, R., et al. “New quinovic acid glycosides from Uncaria tomentosa." J. Nat. Prod. 1988; 51: 257–61.

Para  nao sobrecarregar a página pode ver os estudos sobre a Maytenus krukuvii, A Desmodium adscendens, A Cayaponia tayuya, A Bidens pilosa, A Alchornea castaneifolia, A Smilax officinalis, A Mikania guaco que são centenas nas bases de dados da pubmed do governo dos EUA.


 

Articomplex  120 Capsulas de 650 mg    Preço: 42.20€ .  Portes gratuitos se for  antecipadamente pago por MB ou transferência. À cobrança + 6.00€ - só para Portugal

Encomendas pelo telf:. 21 726 12 09 ou por email:vidarmonia.geral@vidarmonia.pt

  

Preços incluem IVA a taxa legal em vigor - preços podem ser alterados sem aviso prévio. Material sujeito a disponibilidade de stock.